| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CORT | CORCEPT THERAPEUTICS INC | $92.94 | $23.79 | 290.61% | 202.04x | 155.76x | 12.62x | 15.64x | 1.44x | $119.79M | 1.23% | $637.99M | 6.11 | $9.88B | -1,438.71 | ||
| LQDA | LIQUIDIA CORP | $79.47 | $17.40 | 356.66% | 331.13x | 23.14x | 24.28x | 65.09x | 1.63x | $41.15M | 0.59% | $108.58M | 1.23 | $7.03B | 131.15 | ||
| XERS | XERIS BIOPHARMA HOLDINGS INC | $8.67 | $2.78 | 211.66% | 123.86x | 76.12x | 4.70x | 115.04x | 1.19x | $47.52M | 3.22% | $13.01M | 0.08 | $1.64B | 30.76 | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | $323.50 | $91.85 | 252.22% | 74.20x | 43.19x | 10.03x | 40.16x | 1.55x | $641.34M | 1.49% | $1.08B | 8.09 | $44.45B | 48.08 | ||
| KRYS | KRYSTAL BIOTECH INC | $375.40 | $93.89 | 299.85% | 48.44x | 47.96x | 26.35x | 8.67x | 2.31x | $237.38M | 2.16% | $1.28B | 43.59 | $10.57B | 49.42 | ||
| KNSA | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | $64.76 | $17.05 | 279.82% | 66.08x | 50.72x | 6.57x | 8.23x | 1.79x | $164.23M | 3.31% | $605.69M | 7.92 | $4.80B | 43.07 | ||
| RPRX | ROYALTY PHARMA PLC | $58.37 | $39.26 | 48.68% | 30.56x | 10.94x | 10.45x | 3.38x | 0.66x | $2.34B | 9.18% | $9.94B | 22.75 | $41.98B | 36.08 | ||
| ADMA | ADMA BIOLOGICS INC | $9.16 | $9.06 | 1.13% | 13.28x | 10.92x | 4.24x | 5.44x | 0.55x | $107.90M | 4.99% | $390.33M | 1.65 | $2.18B | 9.85 | ||
| HALO | HALOZYME THERAPEUTICS INC | $80.37 | $70.21 | 14.47% | 27.15x | 9.68x | 6.29x | 43.40x | 0.48x | $667.65M | 7.03% | $219.64M | 1.86 | $11.37B | 18.22 | ||
| VCEL | VERICEL CORP | $47.02 | $8.99 | 422.82% | 109.35x | 97.53x | 8.17x | 6.74x | 2.30x | $47.49M | 1.99% | $356.23M | 7.02 | $2.39B | 59.04 | ||
| BMRN | BIOMARIN PHARMACEUTICAL INC | $59.75 | $39.72 | 50.41% | 42.68x | 16.17x | 3.55x | 1.86x | 0.61x | $767.06M | 6.67% | $6.21B | 32.27 | $9.91B | 20.53 | ||
| ASND | ASCENDIS PHARMA A | $277.18 | $79.60 | 248.22% | 29.38x | 18.88x | 16.90x | 29.99x | 2.99x | $52.94M | 0.31% | $574.09M | 9.24 | $17.60B | 188.70 | ||
| JAZZ | JAZZ PHARMACEUTICALS PLC | $248.25 | $48.38 | 413.10% | 528.19x | 9.60x | 3.46x | 3.44x | 1.79x | $1.30B | 8.45% | $4.53B | 73.22 | $19.13B | 28.34 | ||
| TGTX | TG THERAPEUTICS INC | $57.23 | $20.51 | 179.02% | 17.77x | 41.18x | 11.80x | 15.02x | 4.97x | -$14.19M | -0.17% | $583.13M | 4.04 | $9.07B | 60.46 | ||
| LGND | LIGAND PHARMACEUTICALS INC | $314.88 | $92.90 | 238.95% | 39.86x | 34.69x | 22.81x | 6.33x | 2.01x | $122.22M | 1.95% | $997.32M | 50.16 | $6.65B | 29.47 | ||
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $38.08 | $35.25 | 8.02% | 15.05x | 10.43x | 2.45x | 2.42x | 0.57x | $341.79M | 15.52% | $910.35M | 15.75 | $1.77B | 7.49 | ||
| SPRO | SPERO THERAPEUTICS INC | $2.17 | $8.84 | -75.45% | 8.04x | -7.34x | 2.03x | 2.37x | 0.10x | $7.24M | 5.81% | $52.93M | 0.92 | $71.99M | 4.65 | ||
| TECH | BIO-TECHNE CORP | $70.96 | $16.49 | 330.38% | 99.94x | 34.01x | 9.16x | 5.33x | 1.83x | $269.60M | 2.43% | $2.09B | 13.34 | $11.19B | 43.72 | ||
| EXEL | EXELIXIS INC | $56.11 | $30.61 | 83.33% | 17.98x | 17.25x | 6.10x | 7.29x | 1.29x | $917.69M | 6.33% | $1.94B | 7.49 | $14.05B | 13.30 | ||
| UTHR | UNITED THERAPEUTICS CORP | $554.34 | $237.99 | 132.92% | 18.93x | 19.96x | 7.61x | 3.99x | 2.13x | $1.02B | 4.22% | $5.90B | 135.66 | $22.25B | 12.99 | ||
| VRTX | VERTEX PHARMACEUTICALS INC | $498.43 | $165.30 | 201.52% | 29.30x | 25.50x | 10.37x | 6.53x | 2.14x | $3.71B | 2.93% | $19.36B | 76.20 | $123.00B | 22.81 | ||
| NAGE | NIAGEN BIOSCIENCE INC | $3.37 | $2.42 | 39.20% | 14.04x | 14.24x | 2.06x | 3.26x | 0.95x | $4.11M | 1.51% | $82.33M | 1.03 | $204.43M | 9.62 | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $31.47 | $12.59 | 150.02% | 17.39x | 15.80x | 6.44x | 3.80x | 3.25x | $208.13M | 5.41% | $1.01B | 8.28 | $3.10B | 9.25 | ||
| REGN | REGENERON PHARMACEUTICALS INC | $662.88 | $429.01 | 54.51% | 15.58x | 14.08x | 4.62x | 2.21x | 1.05x | $4.11B | 5.97% | $31.42B | 302.15 | $69.24B | 12.05 | ||
| VCYT | VERACYTE INC | $56.12 | $7.50 | 648.67% | 50.56x | 50.61x | 8.24x | 3.33x | 10.68x | $155.34M | 3.48% | $1.34B | 16.90 | $4.25B | 36.96 | ||
| INCY | INCYTE CORP | $117.26 | $63.91 | 83.49% | 16.09x | 14.82x | 4.36x | 4.17x | 1.49x | $1.45B | 6.21% | $5.62B | 28.21 | $20.00B | 10.69 | ||
| MDXG | MIMEDX GROUP INC | $4.26 | $1.22 | 248.86% | 20.29x | -50.59x | 1.62x | 2.61x | 10.68x | $69.36M | 10.96% | $242.94M | 1.64 | $492.33M | 9.04 | ||
| SRPT | SAREPTA THERAPEUTICS INC | $20.21 | $3.20 | 531.35% | 33.68x | 5.52x | 0.97x | 1.42x | 75.05x | $109.24M | 5.15% | $1.51B | 14.34 | $2.71B | 32.71 |